<DOC>
	<DOCNO>NCT01711190</DOCNO>
	<brief_summary>The aim project : 1 . Confirming modification corneal astigmatism trabeculectomy MMC intracameral administration bevacizumab . 2 . Medium-term follow ( 6 month ) induce corneal astigmatism . 3 . Investigating correlation postoperative astigmatism , particularly postoperative IOP .</brief_summary>
	<brief_title>Astigmatism Post-trabeculectomy</brief_title>
	<detailed_description />
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Astigmatism</mesh_term>
	<criteria>Primary open angle glaucoma Normal tension glaucoma Pseudoexfoliation glaucoma Pigment dispersion glaucoma Patients refuse sign inform consent . Patients primary angle closure glaucoma ( PACG ) . Patients young 18 year old . Other ocular disease besides glaucoma . Significant corneal opacity . Refractive error + 6.00 diopter . Visual acuity le 0.05 Previous intraocular surgery ( except cataract surgery six month precede trabeculectomy ) . Laser treatment glaucoma within 6 month surgery .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>trabeculectomy</keyword>
	<keyword>astigmatism</keyword>
	<keyword>intraocular pressure</keyword>
</DOC>